19.01.2017 RHÖN-KLINIKUM AG  DE0007042301

DGAP-Adhoc: RHÖN-KLINIKUM AG: Decision Making Process of Supervisory Board of Rhön- Klinikum concerning Reorganization of Management Board


 
DGAP-Ad-hoc: RHÖN-KLINIKUM AG / Key word(s): Change of Personnel/Miscellaneous RHÖN-KLINIKUM AG: Decision Making Process of Supervisory Board of Rhön- Klinikum concerning Reorganization of Management Board 19-Jan-2017 / 18:20 CET/CEST Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Disclosure of an inside information according to Article 17 EU Market Abuse Regulation (MAR) Rhön-Klinikum AG: Decision Making Process of Supervisory Board of Rhön- Klinikum concerning Reorganization of Management Board Bad Neustadt, 19.01.2017. There is currently a decision making process in the supervisory board of RHÖN-KLINIKUM AG concerning a reorganization of the management board that will be completed in this form no later than Friday, 20 January 2017, 24:00. In case the resolution is passed, the supervisory board would appoint Stephan Holzinger with effect as of 01 February 2017 as member of the management board. Stephan Holzinger has already been a member of the supervisory board of RHÖN-KLINIKUM AG for a number of years; he would resign from this position. Together with his appointment to the management board Stephan Holzinger would at the same time become its chairman. Dr. Dr. Martin Siebert, who has been the chairman so far, would become vice chairman of the management board for personal reasons. Holzinger studied administrative sciences - an interdisciplinary curriculum of law, economics and politics - at the universities of Konstanz and Oslo. His professional carreer led him to US-Senator John W. Warner, Raytheon Inc. and BMW Group. He authored various books and articles on the subject and lectured at universities on communication strategy. High net worth families, members of management and supervisory boards, enterprises and entrepreneurs have relied on his advice regarding strategic reputation management for a decade. Through his position as member of the supervisory board of RHÖN-KLINIKUM AG, as member of the supervisory board of the only private university hospital in Germany in Gießen-Marburg (UKGM) and as director of HCM S.E. he is closely connected to the health care industry. In connection with this reorganization individual responsibilities would be adjusted internally. The supervisory board would finally discuss resulting adjustments of the division of responsibilities within the management board during its next ordinary meeting on 23. February 2016. Your Contact: Dr. Kai G. Klinger (disclosing person) Investor Relations & Corporate Finance RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Telefon: 09771 65-1318 Telefax: 09771 99-1736 Email: [email protected] Achim Struchholz Communication RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Telefon: 09771 65-1327 Telefax: 09771 65-1820 E-Mail: [email protected] --------------------------------------------------------------------------- 19-Jan-2017 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÖN-KLINIKUM AG Salzburger Leite 1 97616 Bad Neustadt a.d.Saale Germany Phone: +49 (0)9771 - 65-0 Fax: +49 (0)9771 - 97 467 E-mail: [email protected] Internet: www.rhoen-klinikum-ag.com ISIN: DE0007042301 WKN: 704230 Indices: SDAX Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange End of Announcement DGAP News Service --------------------------------------------------------------------------- 537895 19-Jan-2017 CET/CEST


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 1.211,08 1.232,91 1.303,90 1.360,16 1.402,01 1.446,09 1.463,98
EBITDA1,2 97,82 125,54 125,33 80,23 101,16 105,65 105,88
EBITDA-Marge3 8,08 10,18 9,61 5,90 7,22 7,31
EBIT1,4 38,70 64,94 56,80 10,60 30,52 36,11 40,40
EBIT-Marge5 3,20 5,27 4,36 0,78 2,18 2,50 2,76
Jahresüberschuss1 36,74 51,19 44,48 2,46 30,23 26,94 40,17
Netto-Marge6 3,03 4,15 3,41 0,18 2,16 1,86 2,74
Cashflow1,7 80,30 49,50 47,30 113,30 97,50 41,30 109,00
Ergebnis je Aktie8 0,53 0,73 0,65 0,02 0,42 0,38 0,58
Dividende8 0,22 0,29 0,00 0,00 0,00 0,15 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
Rhön-Klinikum
WKN Kurs in € Einschätzung Börsenwert in Mio. €
704230 12,500 Halten 837,03
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
20,83 28,40 0,73 21,37
KBV KCV KUV EV/EBITDA
0,67 7,68 0,57 7,31
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,15 0,00 0,00 05.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 07.11.2024 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
10,23% 11,20% 25,00% -3,85%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu RHÖN-KLINIKUM AG  ISIN: DE0007042301 können Sie bei EQS abrufen


Pflegeeinrichtungen , 704230 , RHK , XETR:RHK